Categories Consumer, Finance, Retail

Activist investor wants changes at Dollar Tree, including sale of Family Dollar

Hedge fund Starboard Value LP has taken a 1.7% stake, valued at around $370 million, in Dollar Tree Inc. (DLTR) and is pushing for several changes, including the sale of Family Dollar, according to a report by The Wall Street Journal.

The activist investor is reportedly looking to take majority control on the board of Dollar Tree and is planning to make seven nominations from its end. Starboard also wants the company to make changes to its pricing strategy.

The hedge fund believes that the retailer’s $1-price point, which has not changed in 30 years, is not sustainable in today’s economic environment, and wants the company to start selling products at prices higher than $1.

Apart from these changes, Starboard also wants Dollar Tree to sell the Family Dollar business, which has failed to pick up meaningfully since its acquisition four years ago. According to the report, Starboard does not mind Family Dollar being sold off at a lower price than its acquisition value of $9 billion.

Dollar Tree third-quarter earnings beat estimates despite tariff concerns

However, Dollar Tree appears to have faith in its own strategies while remaining open to shareholder inputs. In its third quarter results announcement, the company said it had plans to renovate at least 1,000 Family Dollar stores and open 350 new Dollar Tree and 200 new Family Dollar stores in 2019. About 200 Family Dollar stores are expected to be re-bannered as well.

Dollar Tree’s shares have dropped more than 12% over the past one year while its peers have done relatively well in comparison. Last quarter the company reduced its outlook for 2018 and now expects sales to come in the range of $22.7 billion to $22.8 billion. As of 2:50 pm ET, the stock was up 4.6%.

 

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips.

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top